The development of COPD in A1AT deficient patients has been clinically linked with alveoli and small airway structural breakdown caused by protease expression, apoptosis and heightened inflammatory response [42, 43, 46]. This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.